Brainsway (BRSYF) Change in Cash (2025 - 2026)

Brainsway posted quarterly Change in Cash of -$9.1 million for Q1 2026, down 501.77% year-on-year from $2.3 million in Q1 2025, and down 501.77% on a QoQ basis from $2.3 million in Q1 2025.

Brainsway (BRSYF) has 2 years of Change in Cash data on file, last reported at -$9.1 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -1.72 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -1.13 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -136.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -504.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -492.00 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -2.23 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.90 Mn
10 Brainsway - - 11.68 Mn -9.06 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -9.06 Mn
Mar 31, 2025 2.26 Mn